Colot, Ernesto D.
HRN: 22-50-85 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/30/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/30/2023
02/05/2023
IV
2.25 Grams
Q 8 Hours
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Optimize Dose
Overall appropriateness: No Optimize Dose